These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15233567)

  • 21. Drug interaction microcomputer software evaluation: PDR's drug interactions and side effects diskettes.
    Poirier TI; Giudici RA
    Hosp Pharm; 1990 Sep; 25(9):839-42, 851. PubMed ID: 10170593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of adverse drug reactions by computerized drug interaction screening.
    Davidson KW; Kahn A; Price RD
    J Fam Pract; 1987 Oct; 25(4):371-5. PubMed ID: 3655673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing 4 classification systems for drug-related problems: processes and functions.
    Björkman IK; Sanner MA; Bernsten CB
    Res Social Adm Pharm; 2008 Dec; 4(4):320-31. PubMed ID: 19064239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of resources for analyzing drug interactions.
    Patel RI; Beckett RD
    J Med Libr Assoc; 2016 Oct; 104(4):290-295. PubMed ID: 27822150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
    Wong CM; Ko Y; Chan A
    Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of four drug interaction screening programs].
    Ing Lorenzini K; Reutemann B; Samer CF; Guignard B; Bonnabry P; Dayer P; Perrier A; Desmeules J
    Rev Med Suisse; 2012 Oct; 8(358):1978-82. PubMed ID: 23198652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug utilization studies within the VIDEOFAR project.
    Maggini M; Menniti Ippolito F; Spila Alegiani S; Traversa G; Fortini M
    Ann Ist Super Sanita; 1991; 27(2):201-6. PubMed ID: 1755571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug utilization studies and drug monitoring in The Netherlands.
    Haaijer-Ruskamp FM; de Jong-van den Berg LT
    Ann Ist Super Sanita; 1991; 27(2):217-23. PubMed ID: 1755574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Data incompatibility of adverse event reports electronically submitted to the AERS database.
    Glass LM
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):212-3. PubMed ID: 18236510
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse reaction database has minimal information.
    Kondro W
    CMAJ; 2005 Jul; 173(2):137. PubMed ID: 16027423
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of nursing-specific drug information PDA databases used as clinical decision support tools.
    Polen HH; Clauson KA; Thomson W; Zapantis A; Lou JQ
    Int J Med Inform; 2009 Oct; 78(10):679-87. PubMed ID: 19640779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ensuring safe medication in the physician's office].
    Niebling W
    MMW Fortschr Med; 2006 May; 148(19):44-5. PubMed ID: 16736706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of drug safety information using large-scale adverse drug reactions database].
    Morikawa K
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2011; (129):1-26. PubMed ID: 22259840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [One step more toward pharmacovigilance 2.0. Integration of web data community for a pharmacovigilance more alert].
    Micoulaud-Franchi JA
    Presse Med; 2011 Sep; 40(9 Pt 1):790-2. PubMed ID: 21802246
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information.
    Chang JS; Pham DA; Dang MT; Lu Y; VanOsdol S; Shin J
    J Med Libr Assoc; 2016 Jan; 104(1):58-61. PubMed ID: 26807054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lessons from cisapride.
    CMAJ; 2001 May; 164(9):1269, 1271. PubMed ID: 11341130
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of drug-interaction alerts in community pharmacies.
    Indermitte J; Beutler M; Bruppacher R; Meier CR; Hersberger KE
    J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The incidence of drug side effects with reference to organ systems. Experience of the spontaneous reporting system of the Swiss Drug Side Effect Center and Comprehensive Drug Monitoring].
    Kuhn M; Hartmann K; Maibach R; Capaul R; Gartmann JC
    Ther Umsch; 1993 Jan; 50(1):8-12. PubMed ID: 8378869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developing a uniform reporting system for preventable adverse drug events.
    Cousins DD
    Clin Ther; 1998; 20 Suppl C():C45-58. PubMed ID: 9915090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [What do health professionals ask RELIS Vest service and how satisfied are they with the answers?].
    Schjøtt J; Pomp E; Gedde-Dahl A; Hundal O; Dybendal T; Opedal K
    Tidsskr Nor Laegeforen; 2000 Jan; 120(2):204-7. PubMed ID: 10851917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.